Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04962672

Anesthesia Induced Brain Cancer Survival (ABC Survival): A Feasibility Study

Led by University Health Network, Toronto · Updated on 2025-01-31

40

Participants Needed

1

Research Sites

195 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cancer is a leading cause of death worldwide. It is estimated that approximately 55,000 Canadians are surviving with brain tumors. It is projected that around 3000 persons will be diagnosed with brain and spinal cord tumors, and approximately 75 percent patients will not survive. Out of all brain cancers, high-grade gliomas \[Glioblastoma Multiforme (GBM)\] impose highest morbidity and mortality. Therefore, it is important to explore ways in which Investigators can improve and prolong the lives of patients suffering from brain cancers, particularly high-grade glioma, which is the most common and aggressive primary brain tumor. So far the Investigators know that the surgery, chemotherapy and radiotherapy are the three corner stones management options for these patients, and majority of the research have been conducted on these three major domains. Therefore, it is imperative to explore the other variables those may impact survival characteristics. One of the integral variables of the brain cancer surgery is anesthesia. Interestingly, the role of anesthetics was explored in some other non-brain solid organ tumor surgeries. It is observed that out of the two main types of anesthesia \[one is through intravenous (propofol) and other one is gaseous (sevoflurane)\], intravenous based anesthesia maintenance regime may delay the cancer progression and prolong the recurrence free period. In addition, two very large retrospective studies with approximately 11,000 and 18,000 patients respectively, showed that as compared to gaseous (volatile anesthetics) based, intravenous (propofol) based anesthesia conferred some protection against cancer progression and was also associated with lesser overall mortality. The exact nature of these protective mechanisms is not known but in animal and other laboratory-based experiments, propofol seems to inhibit cancer formation steps, delays inflammation and provide protection from cancer cell growth. This is a feasibility study for knowing various aspects of workflow; recruitment characteristics of participants and various obstacles in implying anesthesia based protocols so that the Investigators can conduct a well-designed multicenter international randomized study.

CONDITIONS

Official Title

Anesthesia Induced Brain Cancer Survival (ABC Survival): A Feasibility Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient presenting between Jul 1, 2022 and Dec 28, 2023 for elective procedure
  • Male or female aged over 18 years
  • Undergoing primary craniotomy with general anesthesia for suspected high-grade primary glial brain tumor (WHO grade III and IV)
Not Eligible

You will not qualify if you...

  • Pediatric patients and pregnant patients
  • Previously diagnosed with severe adrenal dysfunction (over activity or insufficiency)
  • Suspected low-grade glioma (grade I, II), tumors involving brainstem and optic tract, or non-glial tumors such as suspected brain metastasis
  • Awake craniotomies
  • Any condition preventing postoperative MRI
  • Use of motor evoked potential monitoring or any intraoperative condition affecting anesthetic choice
  • Recurrent Glioblastoma Multiforme (GBM)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Toronto Western Hospital/UHN

Toronto, Ontario, Canada, M5T 2S8

Actively Recruiting

Loading map...

Research Team

E

Emad Al Azazi, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here